Dr. Vogel has more than 20 years of leadership in cancer research with his specific areas of interest being breast cancer risk assessment and prevention. He currently serves as professor of medicine and epidemiology at the University of Pittsburgh School of Medicine, where he is also co-director of the Magee-Womens Hospital/University of Pittsburgh Cancer Institute Biochemoprevention Program. A fellow of the American College of Preventive Medicine and a fellow of the American College of Physicians, Dr. Vogel is board-certified in internal medicine, medical oncology, and general preventive medicine/public health. He served as the National Protocol Chairman of the National Cancer Institute’s STAR Trial (Study of Tamoxifen and Raloxifene).
Dr. Vogel is the author of more than 250 articles, book chapters, and abstracts. He edited the books Management of Patients at High Risk for Breast Cancer and Handbook of Breast Cancer Risk Assessment: Evidence-Based Guidelines for Evaluation, Prevention, Counseling, and Treatment.